Myasthenia gravis (MG) is an autoimmune disease characterized by muscle weakness and
fatiguability of skeletal muscles. It is an antibody-mediated disease, caused by …

Myasthenia gravis (MG) is an autoimmune disease of the neuromuscular junction (NMJ).
Autoantibodies target key molecules at the NMJ, such as the nicotinic acetylcholine receptor …

Given the global surge in autoimmune diseases, it is critical to evaluate emerging
therapeutic interventions. Despite numerous new targeted immunomodulatory therapies …

2014 BMA Medical Book Awards Highly Commended in Pathology category! Muscle Biopsy:
A Practical Approach gives you all of the unparalleled guidance necessary to effectively …

Myasthenia gravis (MG) is the most common autoimmune disorder affecting the
neuromuscular junction, characterized by skeletal muscle weakness and fatigability. It is …

Juvenile Myasthenia Gravis (JMG) is a rare disorder, defined as myasthenia gravis in
children younger than 18 years of age. While clinical phenotypes are similar to adults, there …

The diagnosis of autoimmune Myasthenia Gravis (MG) remains clinical and rests on the
history and physical findings of fatigable, fluctuating muscle weakness in a specific …

Myasthenia gravis: from autoantibodies to therapy : Current Opinion in Neurology
Myasthenia gravis: from autoantibodies to therapy : Current Opinion in Neurology Log in or …

Myasthenia gravis (MG) is a chronic and severe disease of the skeletal neuromuscular
junction (NMJ) in which the effects of neurotransmitters are attenuated, leading to muscle …

Complement activation as a driver of pathology in myasthenia gravis (MG) has been
appreciated for decades. The terminal complement component [membrane attack complex …